UNSPSC 51294803: Gepirone hydrochloride

This classification denotes a serotonin agonist and anxiolytic with the molecular formula C19H29N5O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80C9L8EP6V, chemically known as 3,3-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)glutarimide monohydrochloride but more generally known as gepirone hydrochloride, which bears US NIH Compound Identifier 55190. Most nations, for tariff and trade purposes, schedule gepirone hydrochloride under HS 29335995 and SITC 51576.

As of Q4 2014, GEPIRONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Gepirone hydrochloride bears US NLM identifiers UMLS ID C2348751 and NCI Concept Code C72795. SMILES: CC1(CC(=O)N(C(=O)C1)CCCCN2CCN(CC2)C3NCCCN3)C.CL.

UNSPSC 51294803 Gepirone hydrochloride is a Commodity code for pharmaceutical products, but the recent state and local procurement activity tagged under this code does not align with its nominal scope. Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 for naloxone and drug deactivation systems—opioid-overdose reversal agents and harm-reduction equipment—which fall outside the therapeutic class and chemical specificity of gepirone hydrochloride, an antidepressant compound. The mismatch suggests either a coding error in the opportunity posting or a broad application of the pharmaceutical commodity code to cover multiple product lines within the issuing agency's health procurement.

The single recent opportunity on record is Solicitation IFB60459723LAS, issued by Seminole County, Florida with a response deadline of July 26, 2023 (note: the posting date of June 30, 2026 appears inconsistent with this deadline and likely reflects a data entry error in the source). The county seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bidders must include all shipping and delivery costs, comply with drug-free workplace and E-Verify requirements, maintain specified insurance coverage, and accept a three-month probationary period with termination-at-will provisions. The contract carries a two-year initial term with an option for one-year renewal and potential FEMA funding, which triggers federal compliance obligations. No set-aside designations are specified. This code shows minimal recent activity, and the single solicitation does not substantively reflect gepirone hydrochloride purchasing; pursuit would require clarification of the code's intended scope in this procurement context.